Determinants of uptake of intermittent preventive treatment during pregnancy: a review

Malaria in pregnancy (MiP) contributes to devastating maternal and neonatal outcomes. Coverage of intermittent preventive treatment during pregnancy (IPTp) remains alarmingly low. Data was compiled from MiP programme reviews and performed a literature search on access to and determinants of IPTp. Na...

Descripción completa

Detalles Bibliográficos
Autores principales: Roman, Elaine, Andrejko, Kristin, Wolf, Katherine, Henry, Marianne, Youll, Susan, Florey, Lia, Ferenchick, Erin, Gutman, Julie R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873519/
https://www.ncbi.nlm.nih.gov/pubmed/31752868
http://dx.doi.org/10.1186/s12936-019-3004-7
_version_ 1783472677527224320
author Roman, Elaine
Andrejko, Kristin
Wolf, Katherine
Henry, Marianne
Youll, Susan
Florey, Lia
Ferenchick, Erin
Gutman, Julie R.
author_facet Roman, Elaine
Andrejko, Kristin
Wolf, Katherine
Henry, Marianne
Youll, Susan
Florey, Lia
Ferenchick, Erin
Gutman, Julie R.
author_sort Roman, Elaine
collection PubMed
description Malaria in pregnancy (MiP) contributes to devastating maternal and neonatal outcomes. Coverage of intermittent preventive treatment during pregnancy (IPTp) remains alarmingly low. Data was compiled from MiP programme reviews and performed a literature search on access to and determinants of IPTp. National malaria control and reproductive health (RH) policies may be discordant. Integration may improve coverage. Medication stock-outs are a persistent problem. Quality improvement programmes are often not standardized. Capacity building varies across countries. Community engagement efforts primarily focus on promotion of services. The majority of challenges can be addressed at country level to improve IPTp coverage.
format Online
Article
Text
id pubmed-6873519
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68735192019-12-12 Determinants of uptake of intermittent preventive treatment during pregnancy: a review Roman, Elaine Andrejko, Kristin Wolf, Katherine Henry, Marianne Youll, Susan Florey, Lia Ferenchick, Erin Gutman, Julie R. Malar J Review Malaria in pregnancy (MiP) contributes to devastating maternal and neonatal outcomes. Coverage of intermittent preventive treatment during pregnancy (IPTp) remains alarmingly low. Data was compiled from MiP programme reviews and performed a literature search on access to and determinants of IPTp. National malaria control and reproductive health (RH) policies may be discordant. Integration may improve coverage. Medication stock-outs are a persistent problem. Quality improvement programmes are often not standardized. Capacity building varies across countries. Community engagement efforts primarily focus on promotion of services. The majority of challenges can be addressed at country level to improve IPTp coverage. BioMed Central 2019-11-21 /pmc/articles/PMC6873519/ /pubmed/31752868 http://dx.doi.org/10.1186/s12936-019-3004-7 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Roman, Elaine
Andrejko, Kristin
Wolf, Katherine
Henry, Marianne
Youll, Susan
Florey, Lia
Ferenchick, Erin
Gutman, Julie R.
Determinants of uptake of intermittent preventive treatment during pregnancy: a review
title Determinants of uptake of intermittent preventive treatment during pregnancy: a review
title_full Determinants of uptake of intermittent preventive treatment during pregnancy: a review
title_fullStr Determinants of uptake of intermittent preventive treatment during pregnancy: a review
title_full_unstemmed Determinants of uptake of intermittent preventive treatment during pregnancy: a review
title_short Determinants of uptake of intermittent preventive treatment during pregnancy: a review
title_sort determinants of uptake of intermittent preventive treatment during pregnancy: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873519/
https://www.ncbi.nlm.nih.gov/pubmed/31752868
http://dx.doi.org/10.1186/s12936-019-3004-7
work_keys_str_mv AT romanelaine determinantsofuptakeofintermittentpreventivetreatmentduringpregnancyareview
AT andrejkokristin determinantsofuptakeofintermittentpreventivetreatmentduringpregnancyareview
AT wolfkatherine determinantsofuptakeofintermittentpreventivetreatmentduringpregnancyareview
AT henrymarianne determinantsofuptakeofintermittentpreventivetreatmentduringpregnancyareview
AT youllsusan determinantsofuptakeofintermittentpreventivetreatmentduringpregnancyareview
AT floreylia determinantsofuptakeofintermittentpreventivetreatmentduringpregnancyareview
AT ferenchickerin determinantsofuptakeofintermittentpreventivetreatmentduringpregnancyareview
AT gutmanjulier determinantsofuptakeofintermittentpreventivetreatmentduringpregnancyareview

Ejemplares similares